Q1FY26 EARNING CALENDAR: ADANIGREEN, AJANTPHARM, BEL, GAIL, INDUSINDBK, MAZDOCK, NTPCGREEN, TORNTPHARM, UPL

AHMEDABAD, 28 JULY:

28.07.2025

ACI, ADANIGREEN, AEROFLEX, AJANTPHARM, APOLLO, ARVINDFASN, ARVSMART, ASTEC, ATGL, BAJAJHCARE,BEL, BMW, BPLPHARMA, CARTRADE, CHEMPLASTS, ECORECO, FEDFINA, FIVESTAR, FLAIR, GAIL, GODIGIT, GRAVITA, INDUSINDBK, JKPAPER, KEC, LXCHEM, MANGCHEFER, MAZDOCK, MOLDTKPAC, MSUMI, NACLIND, NTPCGREEN, PARADEEP, PPLPHARMA, PUNJABCHEM, QUESS, RAILTEL, SANGHIIND, SHANKARA, SYSTMTXC, TCI, THANGAMAYL, TORNTPHARM, TTKPRESTIG, UPL, VIDHIING, VIJAYA, WAAREEENER, XPROINDIA

BEL YoY

• Revenue expected at Rs 4714 crore versus Rs 4243 crore

• EBITDA expected to be seen at Rs 1040 crore versus Rs 948 crore

• EBITDA margin expected to be seen at 22.06% versus 22.34%

• Net profit expected to be seen at Rs 836 crore versus Rs 791 crore

GAIL YoY

• Revenue expected at Rs 35611 crore versus Rs 36585 crore

• EBITDA expected to be seen at Rs 3353 crore versus Rs 3216 crore

• EBITDA margin expected to be seen at 9.41% versus 9.01%

• Net profit expected to be seen at Rs 1999 crore versus Rs 2049 crore

INDUSINDBK QoQ

• NII expected at Rs 4030 crore versus Rs 3048 crore

• EBIT expected to be seen at Rs 2321 crore versus Rs -490 crore

• EBIT margin expected to be seen at 39.52% versus -13.07%

• Net profit expected to be seen at Rs 472 crore versus Rs -2328 crore

KEC YoY

• Revenue expected at Rs 5035 crore versus Rs 4511 crore

• EBITDA expected to be seen at Rs 344 crore versus Rs 270 crore

• EBITDA margin expected to be seen at 6.86% versus 5.99%

• Net profit expected to be seen at Rs 117 crore versus Rs 87 crore

TORNTPHARM YoY

• Revenue expected at Rs 3156 crore versus Rs 2859 crore

• EBITDA expected to be seen at Rs 1032 crore versus Rs 904 crore

• EBITDA margin expected to be seen at 32.70% versus 31.62%

• Net profit expected to be seen at Rs 587 crore versus Rs 457 crore

UPL YoY

• Revenue expected at Rs 9528 crore versus Rs 9067 crore

• EBITDA expected to be seen at Rs 1257 crore versus Rs 1101 crore

• EBITDA margin expected to be seen at 13.20% versus 12.14%

• Net profit expected to be seen at Rs -157 crore versus Rs -355 crore

29.07.2025

ABDL, AMBER, APARINDS, ARVIND, ASIANPAINT, ASKAUTOLTD, BANKINDIA, BLISSGVS, BLUEDART, COCKERILL, CRAFTSMAN, DBL, DEEPAKFERT, DPABHUSHAN, ELECTHERM, FOSECOIND, GABRIEL, GALLANTT, GATEWAY, GMRAIRPORT, GREENPLY, GVTD, HAPPSTMNDS, HEIDELBERG, HIRECT, IFBIND, IGIL, JAGRAN, JKIL, JUBLPHARMA, KOLTEPATIL, LT, MASTERTR, NIACL, NILKAMAL, NORTHARC, NOVARTIND, NTPC, PEL, QUADFUTURE, RADHIKAJWE, SIYSIL, SJS, STAR, STARHEALTH, TIMEX, TRIVENI, VBL, VGUARD, VOLTAMP, WELCORP

ASIANPAINT YoY

• Revenue expected at Rs 9034 crore versus Rs 8969 crore

• EBITDA expected to be seen at Rs 1678 crore versus Rs 1693 crore

• EBITDA margin expected to be seen at 18.58% versus 18.88%

• Net profit expected to be seen at Rs 1113 crore versus Rs 1170 crore

 GVTD YoY

• Revenue expected at Rs 1223 crore versus Rs 958 crore

• EBITDA expected to be seen at Rs 233 crore versus Rs 182 crore

• EBITDA margin expected to be seen at 19.09% versus 19.01%

• Net profit expected to be seen at Rs 309 crore versus Rs 134 crore

LT YoY

• Revenue expected at Rs 62746 crore versus Rs 55119 crore

• EBITDA expected to be seen at Rs 6298 crore versus Rs 5651 crore

• EBITDA margin expected to be seen at 10.04% versus 10.19%

• Net profit expected to be seen at Rs 3368 crore versus Rs 2785 crore

NTPC QoQ

• Revenue expected at Rs 48890 crore versus Rs 49833 crore

• EBITDA expected to be seen at Rs 14175 crore versus Rs 14754 crore

• EBITDA margin expected to be seen at 28.99% versus 29.61%

• Net profit expected to be seen at Rs 5480 crore versus Rs 7611 crore

VBL YoY

• Revenue expected at Rs 7134 crore versus Rs 7196 crore

• EBITDA expected to be seen at Rs 1837 crore versus Rs 1991 crore

• EBITDA margin expected to be seen at 25.75% versus 27.67%

• Net profit expected to be seen at Rs 1129 crore versus Rs 1252 crore

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)